| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |